BIXT · Bioxytran, Inc · Executive Compensation
$0.02
0.00 (-7.53%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.73M
Shares
114.70M
Volume · Oct 5
138.67K
Avg daily vol (3M)
99.26K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Mike Sheikh | Officer | Terminated | 2026-01-05 |
| Anders Utter | Board of Directors | Resigned | 2025-12-15 |
| Dr. Radka Milanova | Director | Appointed | 2024-04-19 |